Publisher Correction: Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)

Nadia Harbeck; Eva Ciruelos; Guy Jerusalem; Volkmar Müller; Naoki Niikura; Giuseppe Viale; Rupert Bartsch; Christian Kurzeder; Michaela J. Higgins; Roisin M. Connolly; Sally Baron-Hay; María Gión; Valentina Guarneri; Giampaolo Bianchini; Hans Wildiers; Santiago Escrivá-de-Romaní; Manoj Prahladan; Helen Bridge; Nataliya Kuptsova-Clarkson; Nana Scotto; Sunil Verma; Nancy U. Lin; Carey Anders; Peter Hall; Khalil Zaman; Stefan Aebi; Lorenzo Rossi; Leif Klint; Fredrika Killander; Aglaia Schiza; Purificación Martínez del Prado; Carmen Hinojo González; Encarnación González Flores; César Rodríguez Sanchez; Rafael López López; Javier Cortés Castán; Manuel Ruiz Borrego; Maria Pilar Lopez Marti; Joaquin Gavilá Gregori; Cristina Saura Manich; María Jesús Vidal Losada; Ana Rita Sousa; Fatima Cardoso; Joana Simões; Renata Duchnowska; Jacek Jassem; Barbara Radecka; Zbigniew Nowecki; Piotr Wysocki; Maaike de Boer; DESTINY-Breast12 study group

doi:10.1038/s41591-024-03349-0

Publisher Correction: Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)

Nadia Harbeck^*, Eva Ciruelos, Guy Jerusalem, Volkmar Müller, Naoki Niikura, Giuseppe Viale, Rupert Bartsch, Christian Kurzeder, Michaela J. Higgins, Roisin M. Connolly, Sally Baron-Hay, María Gión, Valentina Guarneri, Giampaolo Bianchini, Hans Wildiers, Santiago Escrivá-de-Romaní, Manoj Prahladan, Helen Bridge, Nataliya Kuptsova-Clarkson, Nana ScottoSunil Verma, Nancy U. Lin, Carey Anders, Peter Hall, Khalil Zaman, Stefan Aebi, Lorenzo Rossi, Leif Klint, Fredrika Killander, Aglaia Schiza, Purificación Martínez del Prado, Carmen Hinojo González, Encarnación González Flores, César Rodríguez Sanchez, Rafael López López, Javier Cortés Castán, Manuel Ruiz Borrego, Maria Pilar Lopez Marti, Joaquin Gavilá Gregori, Cristina Saura Manich, María Jesús Vidal Losada, Ana Rita Sousa, Fatima Cardoso, Joana Simões, Renata Duchnowska, Jacek Jassem, Barbara Radecka, Zbigniew Nowecki, Piotr Wysocki, Maaike de Boer, DESTINY-Breast12 study group

^*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.

Original language	English
Article number	3780
Pages (from-to)	3780
Number of pages	1
Journal	Nature Medicine
Volume	30
Issue number	12
DOIs	https://doi.org/10.1038/s41591-024-03349-0
Publication status	Published - 1 Dec 2024

Access to Document

10.1038/s41591-024-03349-0Licence: CC BY

Fingerprint

Dive into the research topics of 'Publisher Correction: Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)'. Together they form a unique fingerprint.

1 Article

Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial
Harbeck, N., Ciruelos, E., Jerusalem, G., Mueller, V., Niikura, N., Viale, G., Bartsch, R., Kurzeder, C., Higgins, M. J., Connolly, R. M., Baron-Hay, S., Gion, M., Guarneri, V., Bianchini, G., Wildiers, H., Escriva-de-Romani, S., Prahladan, M., Bridge, H., Kuptsova-Clarkson, N. & Scotto, N. & 31 others, Verma, S., Lin, N. U., Yeo, B., Mccarthy, N., Mccartney, A., Clay, T., Murray, N., Gombos, A., Collignon, J., De Cuypere, E., Jerzak, K., Chia, S., Maraldo, M., Ronlev, J., Brix, E., Tanner, M., Mattson, J., Huovinen, R., Wimberger, P., Reinisch, M., Tesch, H., Untch, M., Fasching, P., Park-Simon, T.-W., Tio, J., Braun, M., Grischke, E. M., Marme, F., van Mackelenbergh, M., Et al. & de Boer, M., 1 Dec 2024, In: Nature Medicine. 30, 12, p. 3717–3727 11 p., 967.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Cite this

Harbeck, N., Ciruelos, E., Jerusalem, G., Müller, V., Niikura, N., Viale, G., Bartsch, R., Kurzeder, C., Higgins, M. J., Connolly, R. M., Baron-Hay, S., Gión, M., Guarneri, V., Bianchini, G., Wildiers, H., Escrivá-de-Romaní, S., Prahladan, M., Bridge, H., Kuptsova-Clarkson, N., ... DESTINY-Breast12 study group (2024). Publisher Correction: Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7). Nature Medicine, 30(12), 3780. Article 3780. https://doi.org/10.1038/s41591-024-03349-0

@article{ceac131f3c254e5db4a2df9d4ed52e0b,

title = "Publisher Correction: Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)",

abstract = "Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.",

author = "Nadia Harbeck and Eva Ciruelos and Guy Jerusalem and Volkmar M{\"u}ller and Naoki Niikura and Giuseppe Viale and Rupert Bartsch and Christian Kurzeder and Higgins, {Michaela J.} and Connolly, {Roisin M.} and Sally Baron-Hay and Mar{\'i}a Gi{\'o}n and Valentina Guarneri and Giampaolo Bianchini and Hans Wildiers and Santiago Escriv{\'a}-de-Roman{\'i} and Manoj Prahladan and Helen Bridge and Nataliya Kuptsova-Clarkson and Nana Scotto and Sunil Verma and Lin, {Nancy U.} and Carey Anders and Peter Hall and Khalil Zaman and Stefan Aebi and Lorenzo Rossi and Leif Klint and Fredrika Killander and Aglaia Schiza and {del Prado}, {Purificaci{\'o}n Mart{\'i}nez} and Gonz{\'a}lez, {Carmen Hinojo} and Flores, {Encarnaci{\'o}n Gonz{\'a}lez} and Sanchez, {C{\'e}sar Rodr{\'i}guez} and L{\'o}pez, {Rafael L{\'o}pez} and Cast{\'a}n, {Javier Cort{\'e}s} and Borrego, {Manuel Ruiz} and Marti, {Maria Pilar Lopez} and Gregori, {Joaquin Gavil{\'a}} and Manich, {Cristina Saura} and Losada, {Mar{\'i}a Jes{\'u}s Vidal} and Sousa, {Ana Rita} and Fatima Cardoso and Joana Sim{\~o}es and Renata Duchnowska and Jacek Jassem and Barbara Radecka and Zbigniew Nowecki and Piotr Wysocki and {de Boer}, Maaike and {DESTINY-Breast12 study group}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

day = "1",

doi = "10.1038/s41591-024-03349-0",

language = "English",

volume = "30",

pages = "3780",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "12",

}

Harbeck, N, Ciruelos, E, Jerusalem, G, Müller, V, Niikura, N, Viale, G, Bartsch, R, Kurzeder, C, Higgins, MJ, Connolly, RM, Baron-Hay, S, Gión, M, Guarneri, V, Bianchini, G, Wildiers, H, Escrivá-de-Romaní, S, Prahladan, M, Bridge, H, Kuptsova-Clarkson, N, Scotto, N, Verma, S, Lin, NU, Anders, C, Hall, P, Zaman, K, Aebi, S, Rossi, L, Klint, L, Killander, F, Schiza, A, del Prado, PM, González, CH, Flores, EG, Sanchez, CR, López, RL, Castán, JC, Borrego, MR, Marti, MPL, Gregori, JG, Manich, CS, Losada, MJV, Sousa, AR, Cardoso, F, Simões, J, Duchnowska, R, Jassem, J, Radecka, B, Nowecki, Z, Wysocki, P, de Boer, M & DESTINY-Breast12 study group 2024, 'Publisher Correction: Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)', Nature Medicine, vol. 30, no. 12, 3780, pp. 3780. https://doi.org/10.1038/s41591-024-03349-0

Publisher Correction: Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7). / Harbeck, Nadia; Ciruelos, Eva; Jerusalem, Guy et al.
In: Nature Medicine, Vol. 30, No. 12, 3780, 01.12.2024, p. 3780.

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

TY - JOUR

T1 - Publisher Correction

T2 - Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)

AU - Harbeck, Nadia

AU - Ciruelos, Eva

AU - Jerusalem, Guy

AU - Müller, Volkmar

AU - Niikura, Naoki

AU - Viale, Giuseppe

AU - Bartsch, Rupert

AU - Kurzeder, Christian

AU - Higgins, Michaela J.

AU - Connolly, Roisin M.

AU - Baron-Hay, Sally

AU - Gión, María

AU - Guarneri, Valentina

AU - Bianchini, Giampaolo

AU - Wildiers, Hans

AU - Escrivá-de-Romaní, Santiago

AU - Prahladan, Manoj

AU - Bridge, Helen

AU - Kuptsova-Clarkson, Nataliya

AU - Scotto, Nana

AU - Verma, Sunil

AU - Lin, Nancy U.

AU - Anders, Carey

AU - Hall, Peter

AU - Zaman, Khalil

AU - Aebi, Stefan

AU - Rossi, Lorenzo

AU - Klint, Leif

AU - Killander, Fredrika

AU - Schiza, Aglaia

AU - del Prado, Purificación Martínez

AU - González, Carmen Hinojo

AU - Flores, Encarnación González

AU - Sanchez, César Rodríguez

AU - López, Rafael López

AU - Castán, Javier Cortés

AU - Borrego, Manuel Ruiz

AU - Marti, Maria Pilar Lopez

AU - Gregori, Joaquin Gavilá

AU - Manich, Cristina Saura

AU - Losada, María Jesús Vidal

AU - Sousa, Ana Rita

AU - Cardoso, Fatima

AU - Simões, Joana

AU - Duchnowska, Renata

AU - Jassem, Jacek

AU - Radecka, Barbara

AU - Nowecki, Zbigniew

AU - Wysocki, Piotr

AU - de Boer, Maaike

AU - DESTINY-Breast12 study group

PY - 2024/12/1

Y1 - 2024/12/1

N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.

AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.

U2 - 10.1038/s41591-024-03349-0

DO - 10.1038/s41591-024-03349-0

M3 - Erratum / corrigendum / retractions

SN - 1078-8956

VL - 30

SP - 3780

JO - Nature Medicine

JF - Nature Medicine

IS - 12

M1 - 3780

ER -